| BIGH3 mutation spectrum in corneal dystrophies FL Munier, BE Frueh, P Othenin-Girard, S Uffer, P Cousin, MX Wang, ... Investigative ophthalmology & visual science 43 (4), 949-954, 2002 | 247 | 2002 |
| Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes MA Blasi, AC Tiberti, A Scupola, A Balestrazzi, E Colangelo, P Valente, ... Ophthalmology 117 (8), 1630-1637, 2010 | 110 | 2010 |
| Local chemotherapy with interferon-α for conjunctival mucosa-associated lymphoid tissue lymphoma: a preliminary report MA Blasi, F Gherlinzoni, G Calvisi, P Sasso, M Tani, M Cellini, ... Ophthalmology 108 (3), 559-562, 2001 | 87 | 2001 |
| Photodynamic therapy for vasoproliferative retinal tumors MA Blasi, A Scupola, AC Tiberti, P Sasso, E Balestrazzi Retina 26 (4), 404-409, 2006 | 84 | 2006 |
| The pediatric choroidal and ciliary body melanoma study: a survey by the European Ophthalmic Oncology Group T Rana'a, N Cassoux, L Desjardins, B Damato, L Konstantinidis, ... Ophthalmology 123 (4), 898-907, 2016 | 78 | 2016 |
| Pembrolizumab as first-line treatment for metastatic uveal melanoma E Rossi, MM Pagliara, D Orteschi, T Dosa, MG Sammarco, CG Caputo, ... Cancer Immunology, Immunotherapy 68, 1179-1185, 2019 | 73 | 2019 |
| Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review L Tagliaferri, V Lancellotta, B Fionda, M Mangoni, C Casà, A Di Stefani, ... Human Vaccines & Immunotherapeutics 18 (3), 1903827, 2022 | 55 | 2022 |
| Intralesional interferon-α for conjunctival mucosa-associated lymphoid tissue lymphoma: long-term results MA Blasi, AC Tiberti, P Valente, M Laguardia, MG Sammarco, ... Ophthalmology 119 (3), 494-500, 2012 | 48 | 2012 |
| Long-term outcomes of primary ocular adnexal lymphoma treatment with intraorbital rituximab injections G Savino, R Battendieri, M Gari, CG Caputo, L Laurenti, MA Blasi Journal of cancer research and clinical oncology 139, 1251-1255, 2013 | 47 | 2013 |
| Immunological backbone of uveal melanoma: is there a rationale for immunotherapy? E Rossi, G Schinzari, IG Zizzari, BA Maiorano, MM Pagliara, ... Cancers 11 (8), 1055, 2019 | 43 | 2019 |
| Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma MA Blasi, D Giammaria, E Balestrazzi American journal of ophthalmology 140 (6), 1136-1139, 2005 | 42 | 2005 |
| Photodynamic therapy in ocular oncology MA Blasi, MM Pagliara, A Lanza, MG Sammarco, CG Caputo, G Grimaldi, ... Biomedicines 6 (1), 17, 2018 | 39 | 2018 |
| Dabrafenib and trametinib in BRAF mutant metastatic conjunctival melanoma E Rossi, BA Maiorano, MM Pagliara, MG Sammarco, T Dosa, M Martini, ... Frontiers in Oncology 9, 232, 2019 | 38 | 2019 |
| Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma L Tagliaferri, MM Pagliara, C Masciocchi, A Scupola, L Azario, G Grimaldi, ... Journal of Contemporary Brachytherapy 9 (6), 540-547, 2017 | 38 | 2017 |
| INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures L Tagliaferri, MM Pagliara, L Boldrini, CG Caputo, L Azario, M Campitelli, ... Journal of Contemporary Brachytherapy 9 (3), 287-295, 2017 | 38 | 2017 |
| Conjunctival melanoma: genetic and epigenetic insights of a distinct type of melanoma E Rossi, G Schinzari, BA Maiorano, MM Pagliara, A Di Stefani, E Bria, ... International journal of molecular sciences 20 (21), 5447, 2019 | 35 | 2019 |
| Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: a single institution phase II study G Schinzari, E Rossi, A Cassano, V Dadduzio, M Quirino, M Pagliara, ... Melanoma research 27 (6), 591-595, 2017 | 34 | 2017 |
| Does coenzyme Q10 play a role in opposing oxidative stress in patients with age-related macular degeneration? MA Blasi, C Bovina, G Carella, ML Genova, A Jansen, G Lenaz, ... Ophthalmologica 215 (1), 51-54, 2001 | 34 | 2001 |
| Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications MM Pagliara, L Tagliaferri, L Azario, J Lenkowicz, A Lanza, R Autorino, ... Brachytherapy 17 (2), 432-438, 2018 | 33 | 2018 |
| Efficacy of immune checkpoint inhibitors in different types of melanoma E Rossi, G Schinzari, BA Maiorano, G Indellicati, A Di Stefani, ... Human vaccines & immunotherapeutics 17 (1), 4-13, 2021 | 31 | 2021 |
